J Formos Med Assoc6 Apr 2024
Patients with advanced soft tissue sarcoma who receive sequential multimodal treatments with chemotherapy and surgery have better overall survival compared to those who only receive chemotherapy. Surgery appears to be more beneficial for patients who undergo chemotherapy first. These findings support the use of a…
J Gastrointest Surg5 Apr 2024
Patients with preoperative anemia undergoing curative-intent resection for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) had higher rates of major complications and poorer long-term outcomes. Anemia was associated with worse overall survival, while postoperative transfusions were linked to lower overall survival and recurrence-free survival rates. Preoperative anemia affected…
Eur J Surg Oncol5 Apr 2024
In a comparative study of endoscopic therapy (ET) versus surgical resection for 2-5 cm gastrointestinal stromal tumors, long-term outcomes showed no significant difference in overall or cancer-specific survival rates. After propensity score matching, both groups had comparable survival rates, suggesting that ET may be a…
Surg Endosc3 Apr 2024
Most gastric leiomyomas are benign subepithelial tumors, with few becoming symptomatic or increasing in size. A retrospective review of 231 cases showed that only 2.4% experienced size increase, one of which was leiomyosarcoma. The majority remained stable, with resections confirming leiomyoma. Close monitoring may be…
Am J Surg27 Mar 2024
Rural patients with pancreatic neuroendocrine tumors (pnets) have significantly shorter overall survival (OS) following primary pnet resection compared to urban patients. After adjustments for various factors, living in a rural area remained significantly associated with worse OS. This study highlights survival disparities between rural and…
World J Surg27 Mar 2024
Researchers analyzed data from 1582 patients with small intestinal stromal tumors to identify risk factors for liver metastasis. They found that poor tumor grade, absence of surgery, later T-stage, and no chemotherapy were associated with an increased risk of liver metastasis. A nomogram prediction model…
Ann Surg Oncol21 Mar 2024
Textbook outcome (TO) was achieved in one-third of patients after pancreatoduodenectomy (PD) for nonfunctioning pancreatic neuroendocrine tumors (NF-PANNETs). Tumor size, minimally invasive approach, and surgical volume were predictors of TO. TO was not associated with improved long-term survival, with similar rates seen in patients with…
Dis Colon Rectum17 Mar 2024
Comparing local excision and radical resection for grade 2 rectal neuroendocrine tumors showed no significant difference in survival for tumors ≤1.5 cm. However, tumors >1.5 cm had significantly lower relapse-free survival with local excision. Lymph node metastasis was present in 60% of patients who underwent…
Gastrointest Endosc12 Mar 2024
Endoscopic resection of well-differentiated nonampullary duodenal neuroendocrine tumors was safe and effective, with a high rate of en-bloc and R0 resections. Tumors located in the second part of the duodenum, ≥10mm in size, and with muscularis propria invasion were risk factors for non-curative resection. Adverse…
BMC Surg9 Mar 2024
Multidisciplinary team management in retroperitoneal liposarcoma treatment led to higher overall survival rates at 1, 3, and 5 years, improved diagnostic consistency, reduced perioperative mortality and postoperative complications, and enhanced disease awareness and postoperative compliance. The intervention showed significant benefits in clinical outcomes and diagnostic…